← Back

Bypro 50mg Tablet

Generic: Bicalutamide 50mg
Androgen receptor inhibitorTablet50mg3 brands · 3 makers in Nepal
Bypro is Bicalutamide 50mg, an androgen receptor inhibitor made by Fresenius Kabi pharmaceuticals.
BrandBypro
Generic nameBicalutamide
MakerFresenius Kabi pharmaceuticals
FormTablet
Strength50mg
Source / स्रोतNepalDoc medicine catalog

What it's for

Bicalutamide tablets, USP 50 mg daily are indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate.

From the U.S. FDA-approved label for Bicalutamide. Full label: DailyMed.

Bicalutamide tablets, USP 50 mg daily are indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate.

From the U.S. FDA-approved label for Bicalutamide. Full label: DailyMed.

The recommended dose for bicalutamide tablets therapy in combination with an LHRH analog is one 50 mg tablet once daily (morning or evening). 2.1 Recommended Dose and Schedule The recommended dose for bicalutamide tablets therapy in combination with an LHRH analog is one 50 mg tablet once daily (morning or evening), with or without food. It is recommended that bicalutamide tablets be taken at the same time each day.

Directions from the U.S. FDA-approved label for Bicalutamide — your doctor or pharmacist may advise differently.

Bicalutamide is contraindicated in: Hypersensitivity Bicalutamide is contraindicated in any patient who has shown a hypersensitivity reaction to the drug or any of the tablet’s components. Hypersensitivity reactions including angioneurotic edema and urticaria have been reported., Women Bicalutamide has no indication for women, and should not be used in this population., Pregnancy Bicalutamide can cause fetal harm when administered to a pregnant woman., Hypersensitivity, Women, Pregnancy

Excerpt from the U.S. FDA-approved label for Bicalutamide. Talk to a pharmacist or doctor before use.

Severe hepatic injury and fatal hepatic failure have been observed. Monitor serum transaminase levels prior to starting treatment with bicalutamide, at regular intervals for the first four months of treatment and periodically thereafter, and for symptoms or signs suggestive of hepatic dysfunction. Use bicalutamide with caution in patients with hepatic impairment., Hemorrhage with Concomitant Use of Coumarin Anticoagulant.

Warnings and precautions excerpt from the U.S. FDA-approved label for Bicalutamide — not a complete list. Talk to a pharmacist or doctor before use.

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

Excerpt from the U.S. FDA-approved label for Bicalutamide — not a complete list. Talk to a pharmacist or doctor about side effects.

Utamide 50mg TabletIntas Pharmaceuticals Ltd.

3 brands · 3 makers in the NepalDoc catalog — see the full Bicalutamide guide →

Store at 20° to 25°C (68° to 77°F);

Storage information from the U.S. FDA-approved label for Bicalutamide.

Questions & answers

What is Bypro?

Bypro 50mg Tablet is a Bicalutamide medicine made by Fresenius Kabi pharmaceuticals. It comes as 50mg Tablet.

What is Bypro used for?

According to its FDA label, Bicalutamide is used in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D 2 metastatic carcinoma of the prostate.

What is the generic name of Bypro?

The generic name of Bypro is Bicalutamide.

Which brands of Bicalutamide are available in Nepal?

3 brands of Bicalutamide are listed in the NepalDoc catalog, from 3 makers — including Calutide 50mg Tablet, Utamide 50mg Tablet.

What are the side effects of Bicalutamide?

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

Full medicine guide Check on Medicine Board
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.

NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.
No prices are shown — NepalDoc lists medicine information only.